Abstract
The bcl-2 gene was cloned as a novel gene located at a chromosomal translocation breakpoint in follicular B cell lymphomas by three groups in 19851,2,3 Follicular lymphomas are indolent tumors, difficult to eradicate but slow to progress, and are believed to originate from centrocytic B cells in germinal centers4. 85% or more of follicular lymphomas carry a t(14;18) (q32;q21) leading to the expectation that a new cellular oncogene would be activated by this translocation5,6 The bcl-2 gene is found on chromosome 18 at q21 and juxtaposed in a tail to head fashion to elements of the immunoglobulin heavy chain locus on chromosome 14 in the 14;18 translocation (Figure 1). As expected, the bcl-2-Ig fusion mRNA is overproduced in t(14;18) cells, leading to elevated levels of the 26 kd bcl-2 protein and changes in cellular phenotype7,8.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Tsujimoto, Y., Cossman, J., Jaffe, E. & Croce, C.M., Involvement of the bcl-2 gene in human follicular lymphom, Science 228: 1440–1443 (1985).
Cleary, M.L. & Sklar, J., Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18, Proc Natl Acad Sci USA 82: 7439–7443 (1985).
Bakhshi, A., et al., Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on chromosome 18, Cell 41: 899–906 (1985).
Horning, S.J. & Rosenberg, S.A., The natural history of initially untreated low-grade non-Hodgkin’s lymphomas, N Engl J Med 316: 1471 (1984).
Fukahara, S., Rowley, J.D., Varrakojis, D. & Golomb, H.M., Chromosome abnormalities in poorly differentiated lymphocytic lymphoma, Cancer Res 39: 3119–3131(1979).
Yunis, J.J., et al., Multiple recurrent genomic defects in follicular lymphoma, N Engl J Med 316: 79–84 (1987).
Seto, M., et al., Alternative promoters and exons, somatic mutation and transcriptional deregulation of the Bcl-2-Ig fusion gene in lymphoma EMBO 7: 123–131 (1988).
Chen-Levy, Z., Nourse, J. & Cleary, M.L., The bcl-2 candidate protooncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation, Mol Cell Biol 9: 701–710(1989).
Bakhshi, A., et al., Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners, Proc Natl Acad Sci USA 84: 2396–2400 (1987).
Limpens, J., et al., Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia, Oncogene 6: 2271–2276 (1991).
Aster, J.C., Kobayashi, Y., Shiota, M., Mori, S. & Sklar, J., Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients, Am J Path 141: 291–299 (1992).
Cleary, M.L., Galili, N. & Sklar, J., Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas, J Exp Med 164: 315–320 (1986).
Tsujimoto, Y., et al., DNA rearrangements in human follicular lymphoma can involve either the 5′ or the 3′ region of the bcl-2 gene, Proc Natl Acad Sci USA 84: 1329–1331 (1987).
Adachi, M., Cossman, J., Longo, D., Croce, C.M. & Tsujimoto, Y., Variant translocation of the bcl-2 gene to immunoglobulin light chain gene in chronic lymphocytic leukemia, Poc Natl Acad Sci USA 86: 2771–2774 (1989).
Wyatt, R.T., Ruders, R.A., Zelenetz, A., Delellis, R.A. & Krontiris, T.G., BCL2 oncogene translocation is mediated by a c-like consensus, J Exp Med 175: 1575–1588 (1992).
Jaeger, U., et al., Mechanism of the chromosomal translocation t(14;18) in lymphoma: detection of a 45-Kd breakpoint binding protein, Blood 81: 1833–1840 (1993).
Vaux, D.L., Cory, S. & Adams, J.M., Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cell, Nature 335: 440–442 (1988).
Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. & Korsmeyer, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature 348: 334–336 (1990).
Nunez, G., et al., Deregulated Bcl-2 gene expression selectively prolongs survival of growth-factor-deprived hemopoietic cell lines, J immunol 144: 3602–3610 (1990).
Allsopp, T.E., Wyatt, S., Paterson, H.F. & Davies, A.M., The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis, Cell 73: 295–307 (1993).
McDonnell, T.J., et al., bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation, Cell 57: 79–88 (1989).
McDonnell, T.J., et al., Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population, Mol Cell Biol 10: 1901–1907(1990).
Nunez, G., Hockenbery, D., McDonnell, T.J., Sorenson, C.M. & Korsmeyer, S.J., Bcl-2 maintains B cell memory, Nature 353: 71–73 (1991).
MacLennan, I.C.M. & Gray, D., Antigen-driven selection of virgin and memory B cell, Immunol Rev 91: 61–65 (1986).
Pezzella, F., et al., Expression of the Bcl-2 oncogene protein is not specific for the 14;18 translocation, Am J Path 137: 225–232 (1990).
Hockenbery, D.M., Zutter, M., Hickey, W., Nahm, M. & Korsmeyer, S.J., BCL2 protein is topographically restricted in tissues characterized by apoptotic death, Proc Natl Acad Sci USA 88: 6961–6965 (1991).
Liu, Y.-J., et al., Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis, Eur J Immunol 21: 1905–1910 (1991).
Chleq-Deschamps, C.M., et al., Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues, Blood 81: 293–298 (1993).
Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanegawa, O. & Korsmeyer, S.J., bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes, Cell 67: 879–888 (1991).
Cuende, E., et al., Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cell, EMBO 12: 1555–1560 (1993).
Strasser, A., Harris, A.W. & Cory, S., bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship, Cell 67: 889–899 (1991).
Siegel, R.M., et al., Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice, Proc Natl Acad Sci USA 89: 7003–7007 (1992).
Garcia, I., Martinou, I., Tsujimoto, Y. & Martinou, J.-C., Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene, Science 258: 302–304(1992).
Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P. & Craig, R.W., MCLl, a gene expressed in programmed myeloid differentiation, has sequence similarity to BCL2, Proc Natl Acad Sci USA 90: 3516–3520 (1993).
Tsujimoto, Y., Stress-resistance conferred by high level of bcl-2 protein in human B lymphoblastoid cell line, Oncogene 4: 1331–1336 (1989).
Miyashita, T. & Reed, J.C., Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line, Blood 81: 151–157 (1993).
Walton, M.I., et al., Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis, Cancer Res. 53: 1853–1861 (1993).
Rao, L., et al., The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins, Proc Natl Acad Sci USA 89:7742–7746 (1992).
Levine, B., et al., Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene, Nature 361:739–742 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hockenbery, D.M. (1994). The BCL-2 Gene: A Regulator of Programmed Cell Death. In: Mihich, E., Schimke, R.T. (eds) Apoptosis. Pezcoller Foundation Symposia, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9217-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9217-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9219-5
Online ISBN: 978-1-4757-9217-1
eBook Packages: Springer Book Archive